Roche announced that the FDA has officially approved the Cobas Malaria test, focused on inspecting blood donors for malaria, ...
In this Pharmaceutical Executive video interview, Marie Teil, Global Head of UCB’s Women of Childbearing Age Program, ...
Winrevair is the first FDA-approved activin signaling inhibitor therapy for pulmonary arterial hypertension.
Alexander continues her conversation, touching on topics like disinformation and diversity in clinical trials.
The Supreme Court is set to hear a case that could have a huge impact on not just the availability of Mifepristone, but also ...
Reportedly, the oral weight loss pill VK2735 showed promising signs of effectiveness and a tolerable safety profile.
Eli Lilly announced that two of its brands of insulin will be out stock starting in April. According to a press release, 1 ...
The FDA granted accelerated approval to Elahere in November 2022 for patients with FRα-positive, platinum-resistant ...
A successful DOL engagement approach must be underpinned by a strong operating model for engaging, collaborating with, and ...
In this Pharmaceutical Executive video interview, Marie Teil, Global Head of UCB’s Women of Childbearing Age Program, talks ...
Deal includes the novel treatment CDR132L, which is currently in Phase II clinical trials for heart failure.
AbbVie announced in a press release that it has entered in an agreement with Landos Biopharma to acquire the company. 1 This will bring the clinical stage biopharmaceutical company’s pipeline under ...